Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Citi
Cipla
Healthtrust
Mallinckrodt
McKesson
Baxter
McKinsey
Express Scripts

Generated: August 17, 2017

DrugPatentWatch Database Preview

ISRADIPINE Drug Profile

« Back to Dashboard

What is the patent landscape for Isradipine, and when can generic versions of Isradipine launch?

Isradipine is a drug marketed by Watson Labs Teva, Mylan Pharms Inc, and Elite Labs Inc. and is included in three NDAs.

The generic ingredient in ISRADIPINE is isradipine. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the isradipine profile page.

Summary for Tradename: ISRADIPINE

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list57
Clinical Trials: see list8
Patent Applications: see list4,258
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISRADIPINE at DailyMed

Pharmacology for Tradename: ISRADIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva
ISRADIPINE
isradipine
CAPSULE;ORAL077317-001Jan 5, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ISRADIPINE
isradipine
TABLET, EXTENDED RELEASE;ORAL201067-002Nov 27, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
ISRADIPINE
isradipine
CAPSULE;ORAL077317-002Jan 5, 2006ABRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ISRADIPINE
isradipine
TABLET, EXTENDED RELEASE;ORAL201067-001Nov 27, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Elite Labs Inc
ISRADIPINE
isradipine
CAPSULE;ORAL077169-002Apr 24, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
QuintilesIMS
Fuji
AstraZeneca
US Department of Justice
Colorcon
Daiichi Sankyo
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot